Nilfisk Holding A/S
According to the Market Abuse Regulation art. 19 Nilfisk announces to have received notification regarding acquisition of Nilfisk shares as follows:
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Hans Henrik Lund |
2. | Reason for notification | |
a) | Occupation / title | Group CEO |
b) | First notification /change to notification | First notification |
3. | Further information on the issuer of the securities in question | |
a) | Name | Nilfisk Holding A/S |
b) | LEI code | 529900FSU45YYVLKB451 |
4. | Further information on transaction/transactions: must be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each marketplace where the transactions have been executed | |
a) | Description of the financial instrument, type of instrument / Securities code | Shares DK0060907293 |
b) | Transaction type | Purchase of shares at market price |
c) | Price(s) and volume (s) | Price: DKK 172.95 per share Volume: 11,700 |
d) | Aggregated information - Aggregated volume - Aggregated price | Volume: 11,700 Price: DKK 2,023,515 in total |
e) | Date of the transaction | March 17, 2021 |
f) | Market place of the transaction | Nasdaq Copenhagen (Copenhagen Stock Exchange) |
Contact
Investor Relations
Antonio Tapia
Head of Investor Relations
T: +45 2220 1218
Media Relations
Sara Westphal Emborg
Global Media Relations
T: +45 2067 0833
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom